A peptide discovered by Kunming Animal Institute is expected to be a new drug for the treatment of hypertension
-
Last Update: 2013-09-05
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Hypertension is the most common chronic disease and the main risk factor of cardio cerebrovascular disease Stroke, myocardial infarction, heart failure and chronic kidney disease are the main complications With the improvement of people's living standards, the number of patients with hypertension is increasing year by year, and drugs for the treatment of hypertension have been the focus of drug research and development Under the leadership of researcher Lai Ren, the research group of functional proteomics of natural drugs in the Key Laboratory of animal model and human disease mechanism of Kunming Institute of zoology, Chinese Academy of Sciences, cooperated with Professor Ding Jiuping of Huazhong University of science and technology, found that an endogenous peptide in human body can selectively act on the β subunit of BK channel, and found that it has a good therapeutic effect on hypertension In this study, monkey hypertension model was further used to verify the therapeutic effect The peptide can significantly reduce the diastolic and systolic blood pressure of blood vessels, but also significantly reduce the blood flow speed Therefore, the peptide may be developed as a new drug for the treatment of hypertension The results were published in hypertension, the Journal of hypertension.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
